SpaceX Shares Trade at a 37% Premium, but a Supply Shock and Macro Test Loom

SpaceX’s debut as a publicly traded company has been nothing short of spectacular — but the real pressure is only just beginning. The stock closed its first full week at $185 on Friday, a 37% premium above the $135 issue price that handed early investors a swift paper gain. That blistering start, however, masks two converging threats: a gravitational pull from valuation ratios that would make even the most growth-hungry fund manager wince, and a looming wall of insider shares set to hit the market in the coming weeks.

The initial public offering was a monster by any measure. SpaceX placed more than 638 million shares, raising gross proceeds of nearly $86 billion. On the first day of trading, the stock settled at approximately $161, a level that now serves as a key reference point for analysts watching for downside risk. From there the stock ripped higher, touching above $225 at its peak before a sharp reversal set in. On Wednesday and Thursday alone, the shares shed roughly six to seven percent each session as the initial euphoria gave way to a more sober assessment of what the company actually delivers in terms of revenue and profit.

That profit generation is real, but the numbers are dwarfed by the market’s hopes. The company carries a total market capitalisation of around $2.5 trillion, more than 100 times its annual turnover. The stunning multiple has been artificially supported by a severe scarcity of tradable shares — only about five percent of the 13.18 billion outstanding shares are freely available in the float. Insider holding restrictions and short-selling limits propped up the stock in the early days, creating a supply squeeze that powered the rally.

Now that artificial support is about to erode. The first lock-up period for existing shareholders is tied to the release of second-quarter results, which ends on June 30. After that date, up to 912 million additional shares could stream into the market, an avalanche of supply that would test even the most ardent bulls. To absorb that deluge, passive buying is essential — and fast. Index providers Nasdaq and Russell have already adjusted their rules to accommodate mega-cap newcomers, raising the prospect of rapid inclusion that would trigger automatic purchases by exchange-traded funds and other trackers.

Should investors sell immediately? Or is it worth buying SpaceX?

In the meantime, the operational calendar offers a steady stream of data points. This Sunday, a Falcon 9 rocket is scheduled to lift off from California carrying 24 new Starlink satellites — the 74th SpaceX mission of the year. The first-stage booster, making its 33rd flight, will be recovered by a drone ship at sea, a demonstration of the reusability that underpins the company’s margins. Beyond Starlink, the manifest includes flights for Globalstar and the Space Development Agency, plus the 13th test flight of the enormous Starship system. Each successful launch reinforces the platform’s reliability, a narrative that investors are counting on to justify the current valuation.

Yet the stock’s fate is not solely in SpaceX’s hands. Broad macroeconomic forces will play a decisive role on Thursday, June 25, when the U.S. government publishes fresh inflation and economic growth figures. SpaceX trades as a high-growth technology name, a category acutely sensitive to interest-rate and inflation expectations. If the data come in robust, they will provide cover for the rich multiple. If they disappoint, a rapid test of the first-day close at roughly $161 could be on the cards — a drop of more than 12% from the current level.

For now, the high launch cadence and the promise of index inclusion offer a counterweight to the dilutive shock of the lock-up expiry. But the balancing act is precarious: the company must deliver flawless operational performance while the broader market decides whether $2.5 trillion is a price that makes sense. The next month will provide some answers — and plenty of volatility along the way.